Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients

American Journal of Medicine

Volumn 100, Issue 2, 1996, Pages 186-192

  Janis, Eric M ^a   Allen, David W ^a   Glesby, Marshall J ^a   Carey, Lisa A ^a   Mundy, Linda M ^a   Gopalan, Ramana ^a   Chaisson, Richard E ^a,b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULIN;

ADULT; ARTICLE; CHEMOPROPHYLAXIS; CLONAL ANERGY; CONTROLLED STUDY; FEMALE; HOSPITAL PATIENT; HOST SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; INFECTION RISK; INTRADERMAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0030028565     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)89457-0     Document Type: Article

References (39)

1. Centers for Disease Control. Tuberculosis and human immunodeficiency virus infection. Recommendations of the Advisory Council for the Elimination of Tuberculosis (ACET). MMWR. 1989;38:236-250.
2. Centers for Disease Control. Nosocomial transmission of multi-drug resistant tuberculosis among human immunodeficiency virus-infected persons - Florida and New York, 1988-1991. MMWR. 1991;40:585-591.
3. Fischl M, Uttamchandani R, Daikos G, et al. An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Am Intern Med, 1992;117:177-183.
4. Fischl M, Kaikos G, Uttamchandani R, et al. Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multipledrug-resistant bacilli. Ann Intern Med. 1992;117:184-190.
5. Pearson M, Jereb J, Frieden T, et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. Ann Intern Med. 1992;117:191-196.
6. Barnes P, Bloch A, Davidson P, Snider DJ. Tuberculosis in patients with human immunodeficiency virus infection. NEJM. 1991;324:1644-1650.
7. DiPerri G, Cruciani M, Danzi M, et al. Nosocomial epidemic of active tuberculosis among human immunodeficiency virus-infected patients. Lancet. 1989;2:1502-1504.
8. Daley C, Small P, Schecter G, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus - an analysis using restriction-fragment-length-polymorphism. NEJM. 1992;326:231-235.
9. Selwyn P, Sckell B, Alcabes P, et al. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA. 1992;268:504-509.
10. Moreno S, Baraia-Etxaburu J, Bouza E, et al. Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med. 1993;119:241-243.
11. Centers for Disease Control. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR. 1991;40:27-33.
12. Huebner R, Villarine M, Snider D. Tuberculin skin testing and the HIV epidemic. JAMA 1992;267:409-410. Editorial.
13. Robert C, Hirschel B, Rochat T, Deflon J. Tuberculin skin test reactivity in HIV-seropositive intravenous drug addicts. NEJM. 1989;321:1268-1270.
14. Pesanti E. The negative tuberculin test. Am J Respir Crit Care Med. 1994;149:1699-1709.
15. Kniker W, Anderson C, Roumiantzeff M, The Multi-Test system: a standardized approach to the evaluation of delayed hypersensitivity and cell-mediated immunity. Ann Allergy. 1979;43:73-79.
16. Frazer I, Collins E, Fox J, et al. Assessment of delayed-type hypersensitivity in man: a comparison of the "Multitest" and conventional intradermal injection of six antigens. Clin Immunol Immunopathol. 1985;35:182-190.
17. Grossman J, Baum J, Gluckman J, et al. The effect of aging and acute illness on delayed hypersensitivity. J Allergy Clin Immunol. 1975;55:269-275.
18. Palmer D, Reed W. Delayed hypersensitivity skin testing. I. Response rates in a hospitalized population. II. Clinical correlates and anergy. J Infect Dis. 1974;130:132-143.
19. Reuben J, Hersh E. Delayed hypersensitivity responses of cancer patients to recall antigens using a new "Multitest" applicator. Ann Allergy. 1984;53: 390-394.
20. Walls R. Delayed hypersensitivity to tuberculin and other antigens in a hospital population. S Afr Med J. 1974;48:2073-2076.
21. Barry M, Regan A, Kunches L, et al. Two-stage tuberculin testing with control antigens in patients residing in two chronic disease hospitals. J Am Geriatr Soc. 1987;35:147-153.
22. Canessa P, Fasano L, Lavecchia M, et al. M. Tuberculin skin test in asymptomatic HIV seropositive carriers. Chest. 1989;96:1215-1216.
23. Creditor M, Smith E, Gallai J, et al. Tuberculosis, tuberculin reactivity, and delayed cutaneous hypersensitivity in nursing home residents. J Gerontol. 1988;43:M97-M100.
24. Delafuente J, Meuleman J, Nelson R. Anergy testing in nursing home residents. J Am Geriatr Soc. 1988;36:733-735.
25. Friedman L, Sullivan G, Bevilaqua R, Loscos R. Tuberculosis screening in alcoholics and drug addicts. Am Rev Resp Dis. 1987;136:1188-1192.
26. Sokal J. Measurement of delayed skin-test responses. NEJM. 1975; 293:501-502. Editorial.
27. Buchsbaum D, Buchanan R, Centor R, et al. Screening for alcohol abuse using CAGE scores and likelihood ratios. Ann Intern Med. 1991;115:774-777.
28. Bass J, Farer L, Hopewell P, et al. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med. 1994;149:1359-1374.
29. Block S, Gibbs C, Stevens M, Shulman L. Delayed hypersensitivity in systemic lupus erythematosus. Ann Rheum Dis. 1968;27:311-317.
30. Waldorf D, Willkens R, Decker J. Impaired delayed hypersensitivity in an aging population. Association with antinuclear reactivity and rheumatoid factor. JAMA. 1968;203:831-834.
31. Bovornkitti S, Kangsadal P, Sathirapat P, Oonsombatti P. Reversion and reconversion rate of tuberculin skin reactions in correlation with the use of prednisone. Am Rev Respir Dis. 1960;38:51-55.
32. Janssen R, St. Louis M, Satten G, et al. HIV infection among patients in US acute care hospitals. Strategies for the counseling and testing of hospital patients. NEJM. 1992;327:445-452.
33. Quinn, T. Screening for HIV infection - benefits and costs. NEJM. 1992;327:486-488.
34. Centers for Disease Control. Prevention and control of tuberculosis in US communities with at-risk minority populations and prevention and control of tuberculosis among homeless persons. MMWR. 1992;41:1-11.
35. Centers for Disease Control. Screening for tuberculosis and tuberculosis infection in high-risk populations. Recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR. 1990;39:1-12.
36. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities. MMWR. 1994;43:1-66.
37. Markowitz N, Hansen N, Wilcosky T, et al. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Ann Intern Med. 1993;119: 185-193.
38. Graham N, Nelson K, Solomon L, et al. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and seronegative intravenous drug users. JAMA. 1992;267:369-373.
39. Rodysill K, Hansen L, O'Leary J. Cutaneous delayed hypersensitivity in nursing home and geriatric clinic patients: implications for the tuberculin test. J Am Geriatr Soc. 1989;37:435-443.